Some hospitals and clinics are running up the score on 340B markups, generating billions in profits with no requirement that patients benefit.
Patients lose. Hospitals win.
It's time to fix 340B.
ow.ly/fUEq50ZLtv5
💡 October is Intellectual Property Month. Learn all about how America’s IP system fuels medical breakthroughs and drives patient affordability: ow.ly/OSTS50ZTJFS
$142 BILLION. That’s how much hospitals, clinics, and their for-profit partners pocketed from 340B medicine markups in 2025. Where’s the money going?
Go to PhRMA.org/340B to learn more.
Patients are paying more for health insurance and getting less.
Insurers and PBMs increasingly control access to medicines, while patients face delays, denials and higher costs. A recent study found 70% of brand prescriptions are initially denied by commercial insurers.
It's
Making clinical trials more accessible starts with reaching the right patients.
Better data and partnerships with patient advocacy organizations can help strengthen research, improve clinical trials and support future medical innovation.
More from @TakedaPharma researcher,